Skip to main content

Phibro Animal Health Corporation (PAHC)

NASDAQ: PAHC · IEX Real-Time Price · USD
20.61 -0.77 (-3.60%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap834.78M
Revenue (ttm)852.82M
Net Income (ttm)48.62M
Shares Out40.50M
EPS (ttm)1.20
PE Ratio17.18
Forward PE15.46
Dividend$0.48 (2.33%)
Ex-Dividend DateNov 23, 2021
Volume55,940
Open21.31
Previous Close21.38
Day's Range20.19 - 22.52
52-Week Range18.05 - 31.00
Beta0.57
AnalystsHold
Price Target21.00 (+1.9%)
Earnings DateNov 2, 2021

About PAHC

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industr...

IndustryPharmaceuticals
IPO DateApr 11, 2014
CEOJack Bendheim
Employees1,725
Stock ExchangeNASDAQ
Ticker SymbolPAHC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for PAHC stock is "Hold." The 12-month stock price forecast is 21.00, which is an increase of 1.89% from the latest price.

Price Target
$21.00
(1.89% upside)
Analyst Consensus: Hold

News

Phibro (PAHC) Down 12.3% Since Last Earnings Report: Can It Rebound?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

6 days ago - Zacks Investment Research

Phibro (PAHC) Sales Hurt by Staffing Shortage Amid Pandemic

Internationally, Phibro (PAHC) is registering growth in nutritional specialties driven by strong sales of dairy products.

2 weeks ago - Zacks Investment Research

Phibro Animal Health Corporation to Participate in the 4th Annual Evercore ISI HealthCONx Virtual Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the 4th Annual Evercore ISI Virtual Conference. Chief Financial Officer Damian ...

4 weeks ago - Business Wire

Phirbo (PAHC) Q1 Earnings Lag Estimates, Revenue View Up

Phirbo's (PAHC) year-over-year increase in Q1 sales is primarily due to stronger international demand for poultry and cattle products and more robust growth in the nutritional specialties and vaccine pr...

1 month ago - Zacks Investment Research

Phibro Animal Health Corporation Reports First Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its first quarter ended September 30, 2021. Highlights for the three months ended Sep...

1 month ago - Business Wire

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

1 month ago - Business Wire

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2021 Quarterly Financial Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its first quarter financial results on Tuesday, November 2, 2021, after the market closes. Phibro manag...

1 month ago - Business Wire

Phibro Animal Health Corporation to Participate in the 30th Annual Credit Suisse Virtual Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the 30th Annual Credit Suisse Virtual Healthcare Conference. Chairman, President and...

1 month ago - Business Wire

Why Is Phibro (PAHC) Down 6.1% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

Phibro (PAHC) Q4 Earnings Match Estimates, Margins Down

Phibro (PAHC) sees revenue growth in fourth-quarter fiscal 2021 due to strength in all three segments.

3 months ago - Zacks Investment Research

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its fourth quarter and fiscal year ended June 30, 2021, and provided financial guidan...

3 months ago - Business Wire

Phibro (PAHC) to Report Q4 Earnings: What's in the Cards?

Strength in Mineral Nutrition and Performance Products is expected to have contributed to Phibro's (PAHC) fourth-quarter fiscal 2021 performance.

3 months ago - Zacks Investment Research

Phibro Animal Health Corporation to Participate in Morgan Stanley Virtual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Morgan Stanley Virtual Global Healthcare Conference. Chairman, President and Chi...

3 months ago - Business Wire

Phibro Animal Health Corporation to Participate in Bank of America Virtual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Bank of America Virtual Global Healthcare Conference. Chief Financial Officer Da...

3 months ago - Business Wire

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2021 Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its fourth quarter and fiscal year 2021 financial results on Wednesday, August 25, 2021, after the mark...

4 months ago - Business Wire

PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

PAHC vs. ABT: Which Stock Is the Better Value Option?

Other symbols:ABT
4 months ago - Zacks Investment Research

Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD

Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.

Other symbols:RMDWST
4 months ago - Zacks Investment Research

Pandemic Boosts Animal Health Spending: 4 Stocks to Buy

Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.

Other symbols:IDXXPETQZTS
5 months ago - Zacks Investment Research

3 Discounted MedTech Stocks Poised for Sturdy Growth in 2021

Fundamentally-sound stocks like Henry Schein (HSIC), UnitedHealth Group (UNH) and Phibro Animal Health (PAHC) are trading at a discount and make great picks for the long term.

Other symbols:HSICUNH
5 months ago - Zacks Investment Research

Phirbo (PAHC) Nutritional Specialties Grow, Vaccine Sales Dip

Currently, Phirbo (PAHC) is focused on expanding its footprint in the poultry, swine and cattle industries, in both domestic and international markets.

5 months ago - Zacks Investment Research

5 Probable MedTech Winners Post-COVID on Discounted PEG

Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.

Other symbols:DVAELANEYEHSIC
5 months ago - Zacks Investment Research

PAHC vs. SYK: Which Stock Is the Better Value Option?

PAHC vs. SYK: Which Stock Is the Better Value Option?

Other symbols:SYK
6 months ago - Zacks Investment Research

Here's Why You Should Add Phibro (PAHC) to Your Portfolio

Investors are optimistic about Phibro (PAHC) on solid third-quarter performance and potential in emerging markets.

6 months ago - Zacks Investment Research

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

PAHC vs. SYK: Which Stock Is the Better Value Option?

Other symbols:SYK
6 months ago - Zacks Investment Research

Phibro (PAHC) Q3 Earnings Beat Estimates, Margins Decline

Phibro's (PAHC) fiscal third-quarter revenues improved year over year on growth in Performance Products and Mineral Nutrition segments.

7 months ago - Zacks Investment Research